Eighteen months for one meeting.
That's what it can take to reach the clinical lead who decides whether your product lives. She isn't hiding. She works forty minutes away. There's just no room where the two of you end up.
Eighteen months to one meeting.Or one evening.
The people who actually decide.
A clinical champion who'll tell you where your product breaks in practice. Someone who understands how their organisation really buys, as opposed to how the tender document says it buys. An investor who has seen this pathway before.
- Seating built around what you're working on
- Introductions made personally within the week
- Peers hitting the same regulatory and procurement walls
Every sector, every stage.
Sectors
- Medical devices and diagnostics
- Digital health and health IT
- Biotech and therapeutics
- Pharmaceuticals
- Clinical AI and decision support
- Remote monitoring and virtual care
- Laboratory tools and life science instrumentation
- Dental technology
- Mental and behavioural health
- Femtech, agetech and paediatric health
Models
- B2B
- B2B2C
- Provider-facing
- Payer-facing
- Direct to consumer
- And the hybrids that fit none of those
Stages
- Pre-seed and seed
- Series A and B
- Growth and scale-up
- Established companies opening a Canadian operation
- International companies entering the market
Roles
- Founders and co-founders
- CEOs, COOs and commercial leads
- Heads of clinical, regulatory and market access
- Business development
By application.
Membership is deliberately small and application-based. It takes about ten minutes and asks what you're building, what you need from the room, and what you bring to it.
Guest is invitation only, for people who aren't selling into this sector. Chapter covers every room in your home province. National covers every chapter, plus the summit. Circle is everything, everywhere, plus a hand in shaping the rooms.
What each one opens is covered in the application conversation.